Primary Job Title Chief Medical Officer Primary Organization Hinova Pharma
Location Houston, Texas, United States Regions Greater Houston Area, Southern US Gender Male
LinkedIn View on LinkedIn
Frank Perabo has been ESSA’s Chief Medical Officer since September 2014. His responsibilities include the clinical development of EPI-506 and product candidates. Frank has 18 years of experience in drug development and urologic oncology research.
Before joining ESSA, he was Executive Director, Oncology at Astellas Pharma Global Development,
Inc., where he was instrumental in the development and approval of XTANDITM (Enzalutamide).
Before that, he worked as Global Medical Lead in multiple preclinical to Phase 3 development programs, successfully directing various early and late phase projects at Astellas Europe.
Frank has also served as Scientific Director at Oncology World, Munich, an Oncology Contract Research Organization, and as a consultant on early phase oncology drug development. He obtained his specialist training at the Universities of Munich, Freiburg and Bonn after graduating magna cum laude from medical school at the University of Munich.
He is a European board certified urologist, an Associate Professor of Urology at Bonn University, Germany and a member of several urologic and oncologic associations. Frank has received multiple international awards in urological research.
